SCHEMBL18909677

SCHEMBL18909677

O=C(CCC(=O)OC1CCCC1)NC1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.58
ALDH1A1 P00352 3/20 0.58
EPHX1 P07099 2/20 0.55
HPGD P15428 2/20 0.51
HDAC3 O15379 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
NCOR2 Q9Y618 1/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
NAAA Q02083 2/20 0.49
NPSR1 Q6W5P4 1/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207015 0.82 NAAA (0.64) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL24856036 0.81 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1HPGDHDAC3HDAC1
SCHEMBL10587847 0.80 ALDH1A1 (0.83) SMN1; SMN2ALDH1A1EPHX1HPGDHDAC3
SCHEMBL31069913 0.80 NAAA (0.66) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL7568980 0.80 NAAA (0.66) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL258780 0.80 NAAA (0.66) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL19232285 0.80 NAAA (0.54) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL28448079 0.78 NAAA (0.59) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL3473161 0.75 NAAA (0.56) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA
SCHEMBL31302650 0.75 NAAA (0.59) SMN1; SMN2ALDH1A1EPHX1HPGDNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190085034-A1 ANTIBODY MIMIC CONJUGATES AND PARTICLES TVA (ABC), LLC 2019-03-21 US disclosed
US-20180021454-A1 TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF TVA (ABC), LLC 2018-01-25 US disclosed
US-20170151339-A1 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF TVA (ABC), LLC 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085034-A1 ANTIBODY MIMIC CONJUGATES AND PARTICLES CD47, FCGR3B, FCGR2A SMN1; SMN2 1681/4885ALDH1A1 1521/4885EPHX1 2423/4885
US-20170151339-A1 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF CD47, CD44, FURIN SMN1; SMN2 1057/4885ALDH1A1 1159/4885EPHX1 936/4885
US-20180021454-A1 TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF CD47, CD44, FURIN SMN1; SMN2 946/4885ALDH1A1 1211/4885EPHX1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.